NEW YORK–(BUSINESS WIRE)–Real Chemistry reported $560 million in 2025 revenue, reflecting continued demand for integrated, AI-enabled solutions from molecule to market.
Real Chemistry Delivers Double-Digit Year-Over-Year Growth in 2025 as Tier-One, Tech-Enabled Healthcare Commercialization Partner
